Skip to content
Technology
Pipeline
Overview
NS002 Epinephrine
NS001 Naloxone
About Us
News
Investors
Overview
Press Releases
Events
SEC Filings
Corporate Governance
Stock Information
FAQs
Contact
Technology
Pipeline
Overview
NS002 Epinephrine
NS001 Naloxone
About Us
News
Investors
Overview
Press Releases
Events
SEC Filings
Corporate Governance
Stock Information
FAQs
Contact
Nasus pharma presented clinical results at Fourth Annual – ASPN Conference
July 14, 2022
– July 17, 2022
ASPN Annual Conference July 14-17, 2022, Miami Beach
Download Presentation
View ALL Events
Scroll to Top
Secret Link
